BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23467232)

  • 21. BCR/ABL1 Kinase Domain Mutation Monitoring: Could Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Benefit As Well?
    Andolina JR
    Acta Haematol; 2015; 134(2):69-70. PubMed ID: 25895547
    [No Abstract]   [Full Text] [Related]  

  • 22. Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia.
    Frost BM; Forestier E; Gustafsson G; Nygren P; Hellebostad M; Jonmundsson G; Kanerva J; Schmiegelow K; Larsson R; Lönnerholm G;
    Leukemia; 2005 Jan; 19(1):165-9. PubMed ID: 15526029
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.
    Li B; Brady SW; Ma X; Shen S; Zhang Y; Li Y; Szlachta K; Dong L; Liu Y; Yang F; Wang N; Flasch DA; Myers MA; Mulder HL; Ding L; Liu Y; Tian L; Hagiwara K; Xu K; Zhou X; Sioson E; Wang T; Yang L; Zhao J; Zhang H; Shao Y; Sun H; Sun L; Cai J; Sun HY; Lin TN; Du L; Li H; Rusch M; Edmonson MN; Easton J; Zhu X; Zhang J; Cheng C; Raphael BJ; Tang J; Downing JR; Alexandrov LB; Zhou BS; Pui CH; Yang JJ; Zhang J
    Blood; 2020 Jan; 135(1):41-55. PubMed ID: 31697823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are children with lymphoblastic leukaemia resistant to 6-mercaptopurine because of 5'-nucleotidase?
    Pieters R; Huismans DR; Veerman AJ
    Lancet; 1987 Dec; 2(8573):1471. PubMed ID: 2892037
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacogenomics of acute lymphoblastic leukemia].
    Ansari M; St-Onge G; Krajinovic M
    Med Sci (Paris); 2007 Nov; 23(11):961-7. PubMed ID: 18021708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients.
    Soverini S; De Benedittis C; Papayannidis C; Polakova KM; Venturi C; Russo D; Bresciani P; Iurlo A; Mancini M; Vitale A; Chiaretti S; Foà R; Abruzzese E; Sorà F; Kohlmann A; Haferlach T; Baccarani M; Cavo M; Martinelli G
    Leukemia; 2016 Jul; 30(7):1615-9. PubMed ID: 26867670
    [No Abstract]   [Full Text] [Related]  

  • 27. Building better therapy for children with acute lymphoblastic leukemia.
    Carroll WL; Raetz EA
    Cancer Cell; 2005 Apr; 7(4):289-91. PubMed ID: 15837616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia.
    Schotte D; De Menezes RX; Akbari Moqadam F; Khankahdani LM; Lange-Turenhout E; Chen C; Pieters R; Den Boer ML
    Haematologica; 2011 May; 96(5):703-11. PubMed ID: 21242186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mercaptopurine vs thioguanine for the treatment of acute lymphoblastic leukemia.
    Evans WE; Relling MV
    Leuk Res; 1994 Nov; 18(11):811-4. PubMed ID: 7967707
    [No Abstract]   [Full Text] [Related]  

  • 30. Oligomeric interface modulation causes misregulation of purine 5´-nucleotidase in relapsed leukemia.
    Hnízda A; Škerlová J; Fábry M; Pachl P; Šinalová M; Vrzal L; Man P; Novák P; Řezáčová P; Veverka V
    BMC Biol; 2016 Oct; 14(1):91. PubMed ID: 27756303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrocortisone does not influence glucocorticoid sensitivity of acute lymphoblastic leukemia cells.
    Warris LT; van den Heuvel-Eibrink MM; Ariës IM; Pieters R; van den Akker EL; den Boer ML
    Haematologica; 2015 Apr; 100(4):e137-9. PubMed ID: 25425687
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
    Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
    Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. St Jude researchers use DNA chips to determine how leukemia cells responds to different drug treatments.
    Pharmacogenomics; 2003 May; 4(3):244. PubMed ID: 12774778
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
    Styczynski J; Pieters R; Huismans DR; Schuurhuis GJ; Wysocki M; Veerman AJ
    Br J Haematol; 2000 Sep; 110(4):813-8. PubMed ID: 11054062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia.
    Mousavian Z; Nowzari-Dalini A; Stam RW; Rahmatallah Y; Masoudi-Nejad A
    Cell Oncol (Dordr); 2017 Feb; 40(1):33-45. PubMed ID: 27798768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individualized 6-mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial.
    Tulstrup M; Frandsen TL; Abrahamsson J; Lund B; Vettenranta K; Jonsson OG; Marquart HVH; Albertsen BK; Heyman M; Schmiegelow K
    Eur J Haematol; 2018 Jan; 100(1):53-60. PubMed ID: 28983968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Everything you always wanted to know about cellular drug resistance in childhood acute lymphoblastic leukemia.
    Pieters R; Klumper E; Kaspers GJ; Veerman AJ
    Crit Rev Oncol Hematol; 1997 Jan; 25(1):11-26. PubMed ID: 9134309
    [No Abstract]   [Full Text] [Related]  

  • 38. Thiopurine methyl transferase: activity and genotyping in patients with acute lymphoblastic leukemia.
    Brouwer C; Keizer-Garritsen JJ; Lambooy LH; Ament K; Ter Riet PG; De Abreu RA; Bökkerink JP; Van Wering ER; Van Der Does-Van Den Berg A; Veerman AJ; Trijbels JP
    Adv Exp Med Biol; 2000; 486():327-31. PubMed ID: 11783509
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacogenetics of acute lymphoblastic leukemia treatment response.
    Cunningham L; Aplenc R
    Expert Opin Pharmacother; 2007 Oct; 8(15):2519-31. PubMed ID: 17931087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.
    Pieters R; Huismans DR; Loonen AH; Peters GJ; Hählen K; van der Does-van den Berg A; van Wering ER; Veerman AJ
    Leuk Res; 1992 Sep; 16(9):873-80. PubMed ID: 1405718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.